NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 218 filers reported holding NEVRO CORP in Q3 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,366,000 | -13.7% | 34,481 | +1.6% | 0.00% | -100.0% |
| Q3 2022 | $1,582,000 | +28.0% | 33,954 | +20.4% | 0.00% | – |
| Q2 2022 | $1,236,000 | -35.3% | 28,190 | +6.8% | 0.00% | -100.0% |
| Q1 2022 | $1,910,000 | -4.6% | 26,402 | +1.5% | 0.00% | 0.0% |
| Q4 2021 | $2,003,000 | -32.3% | 26,004 | +2.3% | 0.00% | 0.0% |
| Q3 2021 | $2,960,000 | -82.8% | 25,430 | -75.5% | 0.00% | -80.0% |
| Q2 2021 | $17,234,000 | +41.7% | 103,904 | +19.1% | 0.01% | +25.0% |
| Q1 2021 | $12,161,000 | -6.2% | 87,263 | +16.5% | 0.00% | -20.0% |
| Q4 2020 | $12,958,000 | +49.7% | 74,923 | +20.6% | 0.01% | +25.0% |
| Q3 2020 | $8,654,000 | +16.0% | 62,127 | -0.7% | 0.00% | +33.3% |
| Q2 2020 | $7,461,000 | -5.9% | 62,564 | -21.0% | 0.00% | -25.0% |
| Q1 2020 | $7,925,000 | -8.4% | 79,237 | +7.7% | 0.00% | 0.0% |
| Q4 2019 | $8,651,000 | +28.4% | 73,563 | -6.1% | 0.00% | +33.3% |
| Q3 2019 | $6,737,000 | +64.6% | 78,356 | +24.0% | 0.00% | +50.0% |
| Q2 2019 | $4,094,000 | +9.0% | 63,187 | +5.2% | 0.00% | 0.0% |
| Q1 2019 | $3,755,000 | +129.1% | 60,091 | +42.6% | 0.00% | +100.0% |
| Q4 2018 | $1,639,000 | +16.0% | 42,140 | +69.9% | 0.00% | – |
| Q3 2018 | $1,413,000 | -73.3% | 24,801 | -62.6% | 0.00% | -100.0% |
| Q2 2018 | $5,292,000 | -27.0% | 66,271 | -20.8% | 0.00% | -33.3% |
| Q1 2018 | $7,251,000 | -72.4% | 83,655 | -78.0% | 0.00% | -75.0% |
| Q4 2017 | $26,271,000 | +61.3% | 380,348 | +112.2% | 0.01% | +50.0% |
| Q3 2017 | $16,292,000 | +13.2% | 179,245 | -7.3% | 0.01% | +14.3% |
| Q2 2017 | $14,388,000 | +190.4% | 193,380 | +265.6% | 0.01% | +133.3% |
| Q1 2017 | $4,955,000 | +36.5% | 52,889 | +5.9% | 0.00% | +50.0% |
| Q4 2016 | $3,629,000 | -48.4% | 49,957 | -25.8% | 0.00% | -50.0% |
| Q3 2016 | $7,031,000 | +12.3% | 67,351 | -20.7% | 0.00% | 0.0% |
| Q2 2016 | $6,263,000 | +24.3% | 84,902 | -5.1% | 0.00% | +33.3% |
| Q1 2016 | $5,037,000 | -6.7% | 89,510 | +11.9% | 0.00% | 0.0% |
| Q4 2015 | $5,401,000 | +55.0% | 80,014 | +6.5% | 0.00% | +50.0% |
| Q3 2015 | $3,484,000 | +21.4% | 75,099 | +40.7% | 0.00% | 0.0% |
| Q2 2015 | $2,869,000 | +147.1% | 53,374 | +120.4% | 0.00% | +100.0% |
| Q1 2015 | $1,161,000 | – | 24,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |